EUVIMEDEUVIMED entdecken
Fallbericht

Selektive Retina-Therapie bei Retinopathia centralis serosa mit Pigmentepithelabhebung

C Klatt, H Elsner, E Pörksen, R Brinkmann, A Bunse, R Birngruber, J Roider

Der Ophthalmologe · 2006-10 · 103 (10) · 850-855

DOI: 10.1007/s00347-006-1415-7 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Der Ophthalmologe, 2006-10. Verfasst von C Klatt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Universitätsklinikum Schleswig-Holstein, Campus Kiel, Hegewischstrasse 2, 24105 Kiel. cklatt@ophthalmol.uni-kiel.de. Hauptthemen laut MEDLINE: Laser Therapy. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Selective Retina Therapy (SRT) is a new and innovative laser treatment modality that selectively treats the retinal pigmentary epithelium while sparing the photoreceptors. This therapeutic concept appears to be particularly suitable for treating patients with acute or chronic central serous chorioretinopathy (CSC). We present preliminary results obtained in five patients who had CSC associated with pigmentary epithelium detachment (PED) and serous subretinal fluid (SRF) and who were treated with SRT. METHODS: This case series was made up of five male patients (mean age 47 years) with chronic CSC and SRF resulting from PED. Examinations performed before and at 1 month and 3 months after the treatment were: BCVA, FLA, OCT (Zeiss OCT III). For SRT, confluent treatment of the PED (area of leakage) was carried out using a pulsed frequency-doubled, Q-switched Nd-YLF prototype laser (lambda=527 nm, t= 1.7 s, 100 Hz, energy = 150-250 J). RESULTS: Best corrected visual acuity at baseline was 0.53, while after 4 weeks it was 0.56 and after 12 weeks, 0.5. At baseline leakage was seen at the PED on fluorescein angiography in all patients. After 4 weeks leakage activity was no longer noted on angiography in 4 of 5 patients. OCT at baseline showed SRF at the edge of the PED in all patients, but in 4 of the 5 patients this was no longer detectable after 4 weeks. CONCLUSION: SRT is a safe and effective treatment for patients with CSC in which PED has caused SRF. Not a single case of rip syndrome was observed in this study, even though the PED was treated confluently. Since SRT spares the photoreceptors it is particularly suitable for the treatment of CSC, especially when the origin of leakage is located close to the fovea. The results indicate that SRT leads to reconstruction of the outer blood-retina barrier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laser TherapyAdultChorioretinitisHumansMaleMiddle AgedOphthalmologic Surgical ProceduresPreoperative CareRetinal DetachmentTreatment Outcome

Autor:innen und Institutionen

  • Universitätsklinikum Schleswig-Holstein, Campus Kiel, Hegewischstrasse 2, 24105 Kiel. cklatt@ophthalmol.uni-kiel.de

Zitieren

APA

Klatt, C., Elsner, H., Pörksen, E., Brinkmann, R., Bunse, A., Birngruber, R., & Roider, J. (2006). Selektive Retina-Therapie bei Retinopathia centralis serosa mit Pigmentepithelabhebung. Der Ophthalmologe, 103(10), 850-855. https://doi.org/10.1007/s00347-006-1415-7

Vancouver

Klatt C, Elsner H, Pörksen E, Brinkmann R, Bunse A, Birngruber R, et al. Selektive Retina-Therapie bei Retinopathia centralis serosa mit Pigmentepithelabhebung. Der Ophthalmologe. 2006;103(10):850-855. doi:10.1007/s00347-006-1415-7

BibTeX
@article{Klatt2006,
  author = {Klatt, C and Elsner, H and Pörksen, E and Brinkmann, R and Bunse, A and Birngruber, R and Roider, J},
  title = {Selektive Retina-Therapie bei Retinopathia centralis serosa mit Pigmentepithelabhebung},
  journal = {Der Ophthalmologe},
  year = {2006},
  volume = {103},
  number = {10},
  pages = {850--855},
  doi = {10.1007/s00347-006-1415-7}
}
Kostenlos starten →